Glutathione: New Hope for Parkinson's Disease? A new therapy for Parkinson’s disease is making inroads in some clinics and alternative healing centres. Pioneered by Florida neurologist Dr. David Perlmutter, the new treatment involves administering high doses of the potent antioxidant glutathione, intravenously.
Parkinson's Disease-Treat the Fire, Not the Smoke It has been estimated that in the United States and Canada more than 1.2 million people suffer from Parkinson’s disease. That translates to about one to two cases per 1,000 individuals in the general population.
Parkinson’s Disease Parkinson’s disease affects the elderly, and although it is very different from *Alzheimer_s disease. It is a chronic, slowly progressing and often debilitating disease which ultimately affects the mind and personality.
Parkinson’s disease articles
